Lea Ludwig

Lea Ludwig

Auto-generated profile, based on publicly available information

Lea Ludwig

Clinical Psychology and Psychotherapy, Institute of Psychology, Faculty of Psychology and Human Movement Sciences, University of Hamburg, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Clinical Psychology Review
Verified
Journal Article
Closed access
LLLea Ludwig
Lea Ludwig
DWDirk Werner
Dirk Werner
TLTania M. Lincoln
Tania M. Lincoln

14 September 2021 in Psychosomatic Medicine
Verified
Journal Article
Open access
LBLukas Msc Berezowski
Lukas Msc Berezowski
LLLea Ludwig
Lea Ludwig
AMAlexandra Martin
Alexandra Martin
BLBernd Löwe
Bernd Löwe
MSMeike C. Shedden-Mora
Meike C. Shedden-Mora
Objective: Psychological treatments for somatic symptom disorder and functional somatic syndromes (SSD/FSS) achieve moderate effects only, potentially because of the high chronicity in these patients. Therefore, we aimed to evaluate whether early treatment, that is, treatment in populations at risk or with recent onset, improves outcome. Methods: We conducted a systematic review and meta-analysis of (cluster-)randomized controlled trials evaluating early psychological interventions in the prevention and treatment of SSD/FSS in adults compared with inactive control conditions, standard care, or placebo. Individuals at risk for SSD/FSS, suffering from subthreshold symptoms or new onsets of SSD/FSS, or presenting with SSD/FSS for the first time were included. Results: We identified 30 eligible studies, mostly examining pain-related conditions. Interventions were diverse, ranging from bibliotherapy to cognitive-behavioral therapy. We found positive effects on depression post-treatment (Hedges’ g = 0.12 [95% confidence interval = 0.03–0.2], k = 5) as well as on somatic symptom severity (g = 0.25 [0.096–0.41], k = 17) and health care utilization (g = 0.31 [0.18–0.44], k = 3) at follow-up. However, because of a high risk of bias, sensitivity to corrections for meta-bias, and missing outcome data, findings should be interpreted cautiously. Conclusions: Our review shows that targeting SSD/FSS at an early stage represents a conceptual and practical challenge. Readily accessible interventions addressing transsymptomatic processes of SSD/FSS development and consolidation are highly needed. Future studies are needed to evaluate individuals with diverse symptoms, examine symptom history thoroughly, use placebo controls, and report outcomes completely to determine the efficacy of early psychological interventions for SSD/FSS. PROSPERO Registration: CRD42020140122.

1 February 2020 in Schizophrenia Research
Verified
Journal Article
Closed access
LLLea Ludwig
Lea Ludwig
SMStephanie Mehl
Stephanie Mehl
BSBjörn Schlier
Björn Schlier
KKKatarina Krkovic
Katarina Krkovic
TLTania M. Lincoln
Tania M. Lincoln

1 September 2015 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
LLLea Ludwig
Lea Ludwig
KWKimberley Whitehead
Kimberley Whitehead
MSMichael Sharpe
Michael Sharpe
MRMarkus Reuber
Markus Reuber
JSJ. R. Stone
J. R. Stone

1 January 2021 in Journal of Abnormal Psychology
Verified
Journal Article
Closed access
MKMathias K Kammerer
Mathias K Kammerer
SMStephanie Mehl
Stephanie Mehl
LLLea Ludwig
Lea Ludwig
TLTania M. Lincoln
Tania M. Lincoln
Sleep-related problems are prevalent in patients with psychotic disorders, yet their contribution to fluctuations in delusional experiences is less clear. This study combined actigraphy and experience-sampling methodology (ESM) to capture the relation between sleep and next-day persecutory symptoms in patients with psychosis and prevailing delusions. Individuals with current persecutory delusions (PD; n = 67) and healthy controls (HC; n = 39) were assessed over 6 consecutive days. Objective sleep and circadian rhythm measures were assessed using actigraphy. Every morning upon awakening, subjective sleep quality was measured using ESM. Momentary assessments of affect and persecutory symptoms were gathered at 10 random time points each day using ESM. Robust linear mixed modeling was performed to assess the predictive value of sleep measures on affect and daytime persecutory symptoms. PD showed significantly lower scores for subjective quality of sleep but significantly higher actigraphic-measured sleep duration and efficiency compared with HC. Circadian rhythm disruption was associated with more pronounced severity of persecutory symptoms in HC. Low actigraphy-derived sleep efficiency was predictive of next-day persecutory symptoms in the combined sample. Negative affect was partly associated with sleep measures and persecutory symptoms. Our results imply an immediate relationship between disrupted sleep and persecutory symptoms in day-to-day life. They also emphasize the relevance of circadian rhythm disruption for persecutory symptoms. Therapeutic interventions that aim to reduce persecutory symptoms could benefit from including modules aimed at improving sleep efficacy, stabilizing sleep-wake patterns, and reducing negative affect. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

1 May 2020 in Journal of Abnormal Psychology
Verified
Journal Article
Closed access
LLLea Ludwig
Lea Ludwig
SMStephanie Mehl
Stephanie Mehl
KKKatarina Krkovic
Katarina Krkovic
TLTania M. Lincoln
Tania M. Lincoln